Vincerx Pharma, Inc. (VINC) Tops Q3 EPS by 5c

Vincerx Pharma, Inc. (NASDAQ: VINC) reported Q3 EPS of ($0.17), $0.05 better than the analyst estimate of ($0.22).

For earnings history and earnings-related data on Vincerx Pharma, Inc. (VINC) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
• KULR Technology Group (KULR) Misses Q2 EPS by 39c